ncRNA-driven regulation of PD-L1 in breast cancer: mechanisms of immune escape and therapeutic opportunities.
Multiple RNA molecules control PD-L1 expression in breast cancer, offering diverse targets to restore immunotherapy response.
lncRNAs, miRNAs, and circRNAs regulate PD-L1 expression in breast cancer through diverse transcriptional and post-transcriptional mechanisms, revealing novel ncRNA-based targets to overcome checkpoint therapy resistance. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- narrative_review
- Category
- novel_therapeutics
- Maturity
- Exploratory
- Journal
- Clinical and Experimental Medicine
Why it surfaced
ncRNA-PD-L1 regulatory landscape in breast cancer; novel targets for overcoming immune checkpoint resistance relevant to immunotherapy pipeline.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.